Home LiteratureArticle Details
PMID: 9844020 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle.

Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, Victor RG

Abstract

The neuronal isoform of nitric oxide synthase (nNOS) is highly expressed in mammalian skeletal muscle, but its functional role has not been defined. NO has been implicated in the local metabolic regulation of blood flow in contracting skeletal muscle in part by antagonizing sympathetic vasoconstriction. We therefore hypothesized that nNOS in skeletal muscle is the source of the NO mediating the inhibition of sympathetic vasoconstriction in contracting muscle. In the mdx mouse, a model of Duchenne muscular dystrophy in which dystrophin deficiency results in greatly reduced expression of nNOS in skeletal muscle, we found that the normal ability of skeletal muscle contraction to attenuate alpha-adrenergic vasoconstriction is defective. Similar results were obtained in mutant mice that lack the gene encoding nNOS. Together these data suggest a specific role for nNOS in the local metabolic inhibition of alpha-adrenergic vasoconstriction in active skeletal muscle.

MeSH Terms
Animals Dystrophin/deficiency Male Mice Mice, Inbred C57BL Muscle, Skeletal/blood supply,physiopathology Muscular Dystrophy, Animal/physiopathology Receptors, Adrenergic, alpha/physiology Vasoconstriction/physiology
Chemicals
Dystrophin Receptors, Adrenergic, alpha
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Thomas G D
Department of Internal Medicine, Hypertension Division, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75235, USA. gthom1@mednet.swmed.edu
Sander M
Lau K S
Huang P L
Stull J T
Victor R G
References (43)
43 references, click to expand
  1. Antagonism of vasoconstrictor responses by exercise in the gracilis muscle of the dog.
    J Pharmacol Exp Ther. 1973 Oct;187(1):78-85 PMID: 4355661
  2. ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle.
    J Clin Invest. 1997 Jun 1;99(11):2602-9 PMID: 9169489
  3. Blood vessel structure in Duchenne muscular dystrophy. I. Light and electron microscopic observations in resting muscle.
    Neurology. 1977 Sep;27(9):861-8 PMID: 561343
  4. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat.
    Am J Physiol. 1981 Aug;241(2):H273-8 PMID: 6455924
  5. X chromosome-linked muscular dystrophy (mdx) in the mouse.
    Proc Natl Acad Sci U S A. 1984 Feb;81(4):1189-92 PMID: 6583703
  6. Muscle development in mdx mutant mice.
    Muscle Nerve. 1984 Nov-Dec;7(9):700-4 PMID: 6543918
  7. Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle.
    J Physiol. 1998 Feb 1;506 ( Pt 3):817-26 PMID: 9503340
  8. Functional sympatholysis during muscular activity. Observations on influence of carotid sinus on oxygen uptake.
    Circ Res. 1962 Sep;11:370-80 PMID: 13981593
  9. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
    J Pharmacol Exp Ther. 1986 May;237(2):529-38 PMID: 3009791
  10. Flow-induced release of endothelium-derived relaxing factor.
    Am J Physiol. 1986 Jun;250(6 Pt 2):H1145-9 PMID: 3487253
  11. Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta.
    Circ Res. 1986 Mar;58(3):407-10 PMID: 3013461
  12. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.
    Cell. 1987 Jul 31;50(3):509-17 PMID: 3607877
  13. Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles.
    J Neurol Sci. 1987 Aug;80(1):39-54 PMID: 3612180
  14. Dystrophin: the protein product of the Duchenne muscular dystrophy locus.
    Cell. 1987 Dec 24;51(6):919-28 PMID: 3319190
  15. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy.
    Cell. 1988 Feb 26;52(4):503-13 PMID: 3342447
  16. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells.
    Biochem Biophys Res Commun. 1989 Jan 16;158(1):348-52 PMID: 2912454
  17. Direct regulation of smooth muscle contractile elements by second messengers.
    Biochem Biophys Res Commun. 1989 Sep 15;163(2):929-35 PMID: 2551277
  18. Possible systemic smooth muscle layer dysfunction due to a deficiency of dystrophin in Duchenne muscular dystrophy.
    J Neurol Sci. 1989 Oct;93(1):11-7 PMID: 2681539
  19. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.
    Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2166-70 PMID: 1848694
  20. Differential sensitivity of arteriolar alpha 1- and alpha 2-adrenoceptor constriction to metabolic inhibition during rat skeletal muscle contraction.
    Circ Res. 1991 Jul;69(1):174-84 PMID: 1647277
  21. Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells.
    Mol Pharmacol. 1991 Dec;40(6):923-31 PMID: 1836834
  22. Participation of endothelium-derived relaxing factor and role of cyclic GMP in inhibitory effects of endothelium on contractile responses elicited by alpha-adrenoceptor agonists in rat aorta.
    J Cardiovasc Pharmacol. 1991 Nov;18(5):670-8 PMID: 1723763
  23. Interaction between microvascular alpha 1- and alpha 2-adrenoceptors and endothelium-derived relaxing factor.
    Circ Res. 1992 Jul;71(1):188-200 PMID: 1318795
  24. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle.
    FEBS Lett. 1993 Jan 25;316(2):175-80 PMID: 7678401
  25. Endothelium-dependent relaxation competes with alpha 1- and alpha 2-adrenergic constriction in the canine epicardial coronary microcirculation.
    Circulation. 1993 Apr;87(4):1264-74 PMID: 8384938
  26. The effects of endurance exercise on dystrophic mdx mice. I. Contractile and histochemical properties of intact muscles.
    Proc Biol Sci. 1993 Jul 22;253(1336):19-25 PMID: 8396774
  27. Acute exercise enhances nitric oxide modulation of vascular response to phenylephrine.
    Am J Physiol. 1993 Oct;265(4 Pt 2):H1184-8 PMID: 8238404
  28. Targeted disruption of the neuronal nitric oxide synthase gene.
    Cell. 1993 Dec 31;75(7):1273-86 PMID: 7505721
  29. Fibres of intermediate type 1C and 2C are found continuously in mdx soleus muscle up to 52 weeks.
    Histochemistry. 1993 Oct;100(4):271-6 PMID: 8276641
  30. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle.
    Nature. 1994 Apr 28;368(6474):850-3 PMID: 7512692
  31. Inhibition of alpha 2-adrenergic vasoconstriction during contraction of glycolytic, not oxidative, rat hindlimb muscle.
    Am J Physiol. 1994 Mar;266(3 Pt 2):H920-9 PMID: 7909201
  32. Dystrophin-dependent efficiency of metabolic pathways in mouse skeletal muscles.
    Experientia. 1994 Jun 15;50(6):602-5 PMID: 8020621
  33. Nitric oxide in skeletal muscle.
    Nature. 1994 Dec 8;372(6506):546-8 PMID: 7527495
  34. Dystrophin does not influence regular cytoskeletal architecture but is required for contractile performance in smooth muscle aortic cells.
    Cell Biol Int. 1994 Oct;18(10):947-58 PMID: 7881382
  35. Site-dependent pathological differences in smooth muscles and skeletal muscles of the adult mdx mouse.
    Muscle Nerve. 1995 Jun;18(6):649-57 PMID: 7753128
  36. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.
    Cell. 1995 Sep 8;82(5):743-52 PMID: 7545544
  37. Contribution of endothelium-derived nitric oxide (EDNO) to the skeletal muscle blood flow response to exercise.
    Med Sci Sports Exerc. 1995 Aug;27(8):1145-51 PMID: 7476058
  38. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels.
    J Physiol. 1995 Jul 1;486 ( Pt 1):47-58 PMID: 7562643
  39. Down-regulation of mitochondrial mRNAs in the mdx mouse model for Duchenne muscular dystrophy.
    FEBS Lett. 1995 Nov 20;375(3):268-72 PMID: 7498514
  40. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy.
    J Exp Med. 1996 Aug 1;184(2):609-18 PMID: 8760814
  41. Control of skeletal muscle blood flow during dynamic exercise: contribution of endothelium-derived nitric oxide.
    Sports Med. 1996 Feb;21(2):119-46 PMID: 8775517
  42. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy.
    Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9142-7 PMID: 8799168
  43. Endogenous nitric oxide masks alpha 2-adrenergic coronary vasoconstriction during exercise in the ischemic heart.
    Circ Res. 1997 Feb;80(2):196-207 PMID: 9012742
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1998-12-08
Pages
15090-5
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC24580
Subset
IM
Grants
NHLBI NIH HHS · P01 HL006296 · United States
NHLBI NIH HHS · P01-HL-06296 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com